智通财经APP讯, 药明合联 (02268)发布公告,于2025年4月14日,根据2024年股份计划,其已批准向287名承授人(其中3名为董事,其余284名承授人为集团雇员)授出538.77万股受限制股份,惟须经选定参与者接纳。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.